Results 11 to 20 of about 304,324 (330)
Arta Medica, 2020 Objectives. The aim of the research was to assess the cardiovascular risk in patients with systemic lupus erythematosus (SLE). Materials and Methods.
Victoria Sadovici-Bobeică +5 more
doaj +1 more source
Arthritis & Rheumatology, 2021 To evaluate seroreactivity and disease flares after COVID‐19 vaccination in a multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE).
P. Izmirly +28 more
semanticscholar +1 more source
Arthritis & Rheumatology, 2021 Epidemiologic data on systemic lupus erythematosus (SLE) are limited, particularly for racial/ethnic subpopulations in the US. This meta‐analysis leveraged data from the Centers for Disease Control and Prevention (CDC) National Lupus Registry network of ...
P. Izmirly +10 more
semanticscholar +1 more source
Journal of Medical Case Reports, 2022 Background There is ample evidence indicating that immunosuppressive therapy or immune dysregulation in systemic lupus erythematosus increases the risk for tuberculosis.
Shekhar +2 more
doaj +1 more source
Arthritis & Rheumatism, 2012 OBJECTIVE The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet ...
M. Petri +51 more
semanticscholar +1 more source
Systemic lupus erythematosus-myositis overlap syndrome with lupus nephritis
Journal of Family Medicine and Primary Care, 2020 Systemic lupus erythematosus-myositis overlap syndrome is rare with prognostic implications. Reports suggest that systemic lupus erythematosus-myositis overlap syndrome with lupus nephritis has a variable clinical outcome.
Biswajit Dey +3 more
doaj +1 more source
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Annals of the Rheumatic Diseases, 2019 Our objective was to update the EULAR recommendations for the management of systemic lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic literature review (01/2007–12/2017), followed by modified Delphi method, to form ...
A. Fanouriakis +27 more
semanticscholar +1 more source
Update οn the diagnosis and management of systemic lupus erythematosus
Annals of the Rheumatic Diseases, 2020 Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it can be organ-dominant, posing diagnostic challenges. To date, diagnosis of
A. Fanouriakis +3 more
semanticscholar +1 more source
Systemic lupus erythematosus [PDF]
Postgraduate Medical Journal, 1988 Summary Systemic lupus erythematosus is a common disease--studies throughout the world broadly agree on a prevalence of 1 in 1000 women. Recently an important clinical advance has come from the description of a syndrome of recurrent thrombosis, recurrent abortion and neurological disease associated with antiphospholipid antibodies.
openaire +4 more sources
Systemic Lupus Erythematosus [PDF]
BMJ, 1957 Lupus is a serious, potentially life-threatening disease. Its natural history is to culminate in a crescendo of autoimmunity and organ involvement. Difficulty arriving at the diagnosis may delay institution of therapy, which although helpful brings new problems. The fundamental understanding of this disease has made major strides. There is no consensus
openaire +6 more sources